The inflammatory response in myocardial injury, repair, and remodelling.
TLDR
Biomarker-based approaches are needed to identify patients with distinct pathophysiologic responses and to rationally implement inflammation-modulating strategies in patients with myocardial infarction.Abstract:
Myocardial infarction triggers an intense inflammatory response that is essential for cardiac repair, but which is also implicated in the pathogenesis of postinfarction remodelling and heart failure. Signals in the infarcted myocardium activate toll-like receptor signalling, while complement activation and generation of reactive oxygen species induce cytokine and chemokine upregulation. Leukocytes recruited to the infarcted area, remove dead cells and matrix debris by phagocytosis, while preparing the area for scar formation. Timely repression of the inflammatory response is critical for effective healing, and is followed by activation of myofibroblasts that secrete matrix proteins in the infarcted area. Members of the transforming growth factor β family are critically involved in suppression of inflammation and activation of a profibrotic programme. Translation of these concepts to the clinic requires an understanding of the pathophysiological complexity and heterogeneity of postinfarction remodelling in patients with myocardial infarction. Individuals with an overactive and prolonged postinfarction inflammatory response might exhibit left ventricular dilatation and systolic dysfunction and might benefit from targeted anti-IL-1 or anti-chemokine therapies, whereas patients with an exaggerated fibrogenic reaction can develop heart failure with preserved ejection fraction and might require inhibition of the Smad3 (mothers against decapentaplegic homolog 3) cascade. Biomarker-based approaches are needed to identify patients with distinct pathophysiologic responses and to rationally implement inflammation-modulating strategies.read more
Citations
More filters
Journal ArticleDOI
Basic Signaling in Cardiac Fibroblasts
TL;DR: Roles of cardiac fibroblasts, which actively participate to fundamental regulation of cardiac physiology and physiopathology processes may represent pertinent targets for pharmacological approaches of cardiac diseases and lead to new tracks of therapeutic strategies.
Journal ArticleDOI
Association of serum HMGB2 level with MACE at 1 mo of myocardial infarction: Aggravation of myocardial ischemic injury in rats by HMGB2 via ROS.
Zhu Hui Liu,Dao Peng Dai,Feng Hua Ding,Wen Qi Pan,Yue Hua Fang,Qi Zhang,Man Li,Ping Yang,Xiao Qun Wang,Ying Shen,Ling Jie Wang,Xiao Xiang Yan,Yu Hu He,Ke Yang,Rui Yan Zhang,Weifeng Shen,Ying Chen,Lin Lu +17 more
TL;DR: It is demonstrated that serum high-mobility group box 2 is associated with major adverse cardiac events at 1 mo in myocardial infarction patients.
Journal ArticleDOI
The role of dendritic cells regulated by HMGB1/TLR4 signalling pathway in myocardial ischaemia reperfusion injury.
TL;DR: The results indicate that DCs activation and maturation, stimulate the expression of surface costimulatory molecules by promoting the release of inflammatory factors through NF‐κB pathway and participate in myocardial IRI.
Journal ArticleDOI
An activatable PET imaging radioprobe is a dynamic reporter of myeloperoxidase activity in vivo.
Cuihua Wang,Edmund J. Keliher,Matthias W.G. Zeller,Gregory R. Wojtkiewicz,Aaron D. Aguirre,Leonard Buckbinder,Hye-Yeong Kim,Jianqing Chen,Kevin P. Maresca,Maaz S. Ahmed,Negin Jalali Motlagh,Matthias Nahrendorf,John W. Chen +12 more
TL;DR: The developed and validated a positron emission tomography radioprobe to noninvasively report on the activity of the damaging enzyme myeloperoxidase secreted by proinflammatory innate immune cells, indicating that 18F-MAPP is a promising translational candidate to non invasively monitor MPO activity and inflammation in patients.
Journal ArticleDOI
Inflammageing in the cardiovascular system: mechanisms, emerging targets, and novel therapeutic strategies
Danlin Liu,Gavin D. Richardson,Gavin D. Richardson,Fehmi M Benli,Catherine Park,João V de Souza,Agnieszka K. Bronowska,Ioakim Spyridopoulos,Ioakim Spyridopoulos +8 more
TL;DR: The 'druggability' of NLRP3 and nicotinic α7 receptors by small molecules is addressed, as these proteins represent novel and exciting targets for therapeutic interventions targeting inflammageing in the cardiovascular system and beyond.
References
More filters
Journal ArticleDOI
Getting to the site of inflammation: the leukocyte adhesion cascade updated
TL;DR: This Review focuses on new aspects of one of the central paradigms of inflammation and immunity — the leukocyte adhesion cascade.
Journal ArticleDOI
DAMPs, PAMPs and alarmins: all we need to know about danger
TL;DR: The term “alarmin” is proposed to categorize such endogenous molecules that signal tissue and cell damage, and can be considered subgroups of a larger set, the damage‐associated molecular patterns (DAMPs).
Journal ArticleDOI
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
Harvey D. White,R M Norris,Michael A. Brown,Peter W.T. Brandt,Ralph M.L. Whitlock,Chris J. Wild +5 more
TL;DR: Volume, ejection fractions, and severity of coronary arterial occlusions and stenoses in 605 male patients under 60 years of age at 1 to 2 months after a first or recurrent myocardial infarction showed that end-systolic volume had greater predictive value for survival than end-diastolic volume or ejection fraction.
Journal ArticleDOI
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
TL;DR: Left ventricular end-diastolic and end-systolic volume and ejection fraction data provide support for the beneficial effects of therapeutic agents such as angiotensin-converting enzyme (ACE) inhibitors and beta-adrenergic blocking agents on the remodeling process.
Related Papers (5)
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker,Brendan M. Everett,Tom Thuren,Jean G. MacFadyen,William Chang,Christie M. Ballantyne,Francisco H. Fonseca,Jose C. Nicolau,Wolfgang Koenig,Stefan D. Anker,John J.P. Kastelein,Jan H. Cornel,Prem Pais,Daniel Pella,Jacques Genest,Renata Cifkova,Alberto J. Lorenzatti,Tamás Forster,Zhanna Kobalava,Luminita Vida-Simiti,Marcus Flather,Hiroaki Shimokawa,Hisao Ogawa,Mikael Dellborg,Paulo Roberto Ferreira Rossi,Roland P.T. Troquay,Peter Libby,Robert J. Glynn +27 more